One could speculate that systemic induction of hepatic or vascular Epo alters the Epo gradient between the circulation and tissues, so provoking an egress of EpoR-positive cancer stem cells from dormant locations (bone marrow or pancreas) into the circulation and/or from the circulation to remote niches (pancreas or liver). This evidence concerns the gene EPO and cancer.